comprehensive -WSS

comprehensive

author：knowledge 2025-10-06 14:21:51 - browse：99

Hevolution's executive team includes, from left, Sophia Pathai, Haya Bint Khaled Bin Bandar Al Saud, Mehmood Khan, and Salman AlAsiry. Courtesy Hashem Al-Sh

The Hevolution Foundation, a Saudi investment firm focused on aging science, said Wednesday that it is launching an incubator that will bring together experts from the scientific community, pharma, and multiple biotech VCs.

The incubator, called the Breakthrough Innovation Alliance, will give up to $1 million apiece to 10 different research initiatives over the next three years, allowing scientists and entrepreneurs to run preclinical research to determine whether the ideas hold any promise. The projects will be evaluated by a committee made up of representatives from Hevolution, Novo Nordisk, 5AM Ventures, RA Capital, and drug company EvoTec. The best projects will become the basis of new startups, co-funded by Hevolution.

It’s all part of Hevolution’s plan to funnel up to $1 billion each year into academic research and biotech startups that are focused on aging-related diseases and and helping people live healthier lives longer, or what is sometimes referred to as “healthspan.” As part of that effort, the firm also announced at a conference in the Saudi capital of Riyadh this week that it will give around $80 million to a handful of research initiatives, including $21 million to establish a partnership with the Buck Institute for Research on Aging.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Celiac disease study examines precisely how gluten triggers injury

WSS

Argenx drug significantly slows progression of nerve disorder

Manchin, Huntsman team up to talk platform for 'unity' ticket that could run in 2024

Blood tests recalled over risk of missed heart attack diagnosis

Care demand spikes challenge UnitedHealth’s provider arm

It's been 20 years since Dolly the sheep. Where's my clone?

Ukraine and a new approach to mental health in war

entertainment

comprehensive

entertainment

Wildfire smoke exposes gaps in outdoor worker protections

How Vertex's cystic fibrosis drug is changing patients' lives

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Lasker Awards 2023: Winners in biomedical research

Peter Hotez and the public health issue of online harassment

The new HIV moral panic

Virginia high school admissions case could be legal follow

Congress: Eradicate hepatitis C and reduce the deficit

Medical leaders decry Supreme Court decision on affirmative action

Involuntary treatment for addiction doesn't work

focus

Biotech lab space demand falls sharply

Argenx drug significantly slows progression of nerve disorder

STAT Virtual Event: Putting AI to the Test

Eli Lilly to acquire Versanis in heated race for weight loss drugs

Senators: Long

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

leisure time

explore

focus

explore